Displaying drugs 12851 - 12875 of 14392 in total
AK119
AK119 is a humanized anti-CD73 monoclonal antibody being investigated in the clinical trial NCT04516564 (A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects).
Investigational
Biomodulin T
Biomodulin T is a polypeptide fraction from bovine thymus with immunomodulatory effects.
Investigational
KB109
KB109 is a prebiotic to feed healthy bacteria for them to to outcompete multi-drug resistance organisms.
Investigational
Escherichia coli
Experimental
Lactobacillus fermentum
Experimental
Lactobacillus gasseri
Experimental
Bifidobacterium breve
Experimental
Bifidobacterium animalis lactis
Experimental
Gentiana lutea extract
Experimental
Bungarus candidus antivenom
Experimental
Wheat germ oil
Experimental
Tetanus immune globulin, equine
Experimental
Liprotamase protease
Experimental
Pygeum africanum bark
Experimental
Paeonia lactiflora root
Experimental
Artemisia annua leaf
Experimental
Citrus aurantium fruit
Experimental
Cinnamon leaf oil
Experimental
Fucus vesiculosus
Experimental
Cryptomeria japonica bark
Experimental
Cnidium monnieri fruit
Experimental
Zagotenemab
Zagotenemab is under investigation in clinical trial NCT03518073 (A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease).
Investigational
Cadonilimab
Cadonilimab is under investigation in clinical trial NCT04220307 (A Study of a PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal Carcinoma).
Investigational
Odronextamab
Odronextamab is a hinge-stabilized, fully human immunoglobulin G4 (IgG4)-based CD20×CD3 bispecific antibody currently evaluated for the treatment of relapsed/refractory (R/R) B-Cell non-Hodgkin lymphoma (NHL).[A254187,A254197] Preliminary studies have shown that in patients with R/R NHL, the use of odronextamab does not lead to the development of neurologic toxicity; however, it can...
Investigational
Matched Description: … [A254187] In December 2020, the FDA placed a partial clinical hold and requested the drug developer, …
Resamirigene bilparvovec
AT132 is under investigation in clinical trial NCT03199469 (Gene Transfer Clinical Study in X-linked Myotubular Myopathy).
Investigational
Displaying drugs 12851 - 12875 of 14392 in total